Log In
Print
BCIQ
Print
Print this Print this
 

GSK2618960

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionAnti-IL-7 mab
Molecular Target Interleukin-7 (IL-7)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat relapsing-remitting multiple sclerosis (RRMS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today